Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage
Author(s) -
Xiurong Zhao,
Guanghua Sun,
Jie Zhang,
Roger Strong,
Pramod K. Dash,
Yuet Wai Kan,
James C. Grotta,
Jaroslaw Aronowski
Publication year - 2007
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.107.486506
Subject(s) - sulforaphane , medicine , intracerebral hemorrhage , oxidative stress , brain damage , cytotoxic t cell , myeloperoxidase , pharmacology , pathogenesis , keap1 , transcription factor , spontaneous intracerebral hemorrhage , immunology , inflammation , anesthesia , cancer research , biochemistry , biology , in vitro , gene , subarachnoid hemorrhage
Intracerebral hemorrhage (ICH) remains a major medical problem for which there is no effective treatment. Oxidative and cytotoxic damage plays an important role in ICH pathogenesis and may represent a target for treatment of ICH. Recent studies have suggested that nuclear factor-erythroid 2-related factor 2 (Nrf2), a pleiotropic transcription factor, may play a key role in protecting cells from cytotoxic/oxidative damage. This study evaluated the role of Nrf2 in protecting the brain from ICH-mediated damage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom